¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"REC"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
  • JrId: 8283
    JournalTitle: Receptors & channels.
    MedAbbr: Receptors Channels
    ISSN: 1060-6823
    ESSN:
    IsoAbbr: Recept. Channels
    NlmId: 9315376
  • JrId: 20212
    JournalTitle: Recruitment, retention & restructuring report.
    MedAbbr: Recruit Retent Restruct Rep
    ISSN:
    ESSN:
    IsoAbbr:
    NlmId: 9436564
  • JrId: 20434
    JournalTitle: Receptors & signal transduction.
    MedAbbr: Recept Signal Transduct
    ISSN: 1087-8475
    ESSN:
    IsoAbbr:
    NlmId: 9617134
  • JrId: 20681
    JournalTitle: Recherche en soins infirmiers.
    MedAbbr: Rech Soins Infirm
    ISSN: 0297-2964
    ESSN:
    IsoAbbr:
    NlmId: 9715370
  • JrId: 21836
    JournalTitle: Records of the Australian Museum.
    MedAbbr:
    ISSN: 0067-1975
    ESSN:
    IsoAbbr: Rec. Aust. Mus.
    NlmId: 100962881
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
  • F33
    Recurrent depressive disorder
    Àç¹ß¼º ¿ì¿ï¼º Àå¾Ö
  • F33.0
    Recurrent depressive disorder, current episode mild
    Àç¹ß¼º ¿ì¿ï¼º Àå¾Ö, ÇöÀç °æµµ
  • F33.1
    Recurrent depressive disorder, current episode moderate
    Àç¹ß¼º ¿ì¿ï¼º Àå¾Ö, ÇöÀç ÁߵÁõ
  • F33.3
    Recurrent depressive disorder, current episode severe with psychotic symptoms
    Àç¹ß¼º ¿ì¿ï¼º Àå¾Ö, ÇöÀç Á¤½Åº´Àû Áõ»óÀÌ ÀÖ´Â ÁßÁõ
  • F33.2
    Recurrent depressive disorder, current episode severe without psychotic symptoms
    Àç¹ß¼º ¿ì¿ï¼º Àå¾Ö, ÇöÀç Á¤½Åº´Àû Áõ»óÀÌ ¾ø´Â ÁßÁõ
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • reciprocal articulation
    »óÈ£°üÀý
  • reciprocal click
    ¿ªÂ°±ïÀ½, ¿ªÅ¬¸¯
  • reciprocal conduction
    »ó¹ÝÀüµµ
  • reciprocal crossing
    ¿ª±³¹è
  • reciprocal inhibition
    »ó¹Ý¾ïÁ¦, »óÈ£¾ïÁ¦
  • reciprocal inhibition psychotherapy
    »óÈ£¾ïÁ¦Á¤½Å¿ä¹ý, »ó¹Ý¾ïÁ¦Á¤½Å¿ä¹ý
  • reciprocal innervation
    »ó¹Ý½Å°æºÐÆ÷, »óÈ£½Å°æºÐÆ÷, »ó¹Ý½Å°æÁö¹è
  • reciprocal rhythm
    Àç±Í¸®µë
  • reciprocal shaker
    ¿Õº¹ÁøÅÁ±â
  • reciprocating gait orthosis
    »ó¹Ýº¸ÇຸÁ¶±â
  • recirculation
    Àç¼øÈ¯
  • recirculation time
    Àç¼øÈ¯½Ã°£
  • reclaiming process
    Àç»ý¹ý
  • reclamation
    ÀçÀÌ¿ë
  • recognition
    1. ÀνÄ, ÀÎÁö 2. ½ÂÀÎ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • rectangular coordinate
    Á÷°¢ÁÂÇ¥
  • rectification
    ±³Á¤, Á¤·ù
  • rectifier
    Á¤·ù±â
  • rectitis
    (¢¡proctitis) °ðâÀÚ¿°, Á÷Àå¿°
  • rectocele
    °ðâÀÚÅ»ÃâÁõ, Á÷Àå·ù
  • rectocolitis
    Á÷ÀåÀß·ÏâÀÚ¿°, Á÷Àå°áÀå¿°
  • rectoscope
    Á÷Àå°æ, °ðâÀÚº¸°³
  • rectovaginal fistula
    °ðâÀÚÁú»û±æ, Á÷ÀåÁú·ç
  • rectovaginal septum
    Á÷ÀåÁú»çÀ̸·, °ðâÀÚÁú»çÀ̸·
  • rectum
    Á÷Àå, °ðâÀÚ
  • rectus
    °ðÀº-, Á÷-
  • rectus abdominis flap
    ¹è°ðÀº±ÙÆÇ, º¹Á÷±ÙÆÇ
  • rectus femoris muscle
    ³Ò´Ù¸®°ðÀº±Ù
  • rectus sheath
    ¹è°ðÀº±ÙÁý
  • recumbent
    ´©¿î-
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • recessive gene
    ¿­¼ºÀ¯ÀüÀÚ
  • recessive hereditary disease
    ¿­¼ºÀ¯Àüº´
  • recessive heredity
    ¿­¼ºÀ¯Àü
  • recessive homozygote
    ¿­¼ºÈ£¸ðÁ¢ÇÕü
  • recessive inheritance
    ¿­¼ºÀ¯Àü
  • recessive mutation
    ¿­¼ºµ¹¿¬º¯ÀÌ
  • recessive trait
    ¿­¼º¼ÒÁú
  • recessus
    (¢¡recess) ¿À¸ñ
  • recipient
    ¹Þ´ÂÀÌ, ¹Þ´ÂºÎÀ§
  • reciprocal articulation
    »óÈ£°üÀý
  • reciprocal click
    ¿ªÂ°±ïÀ½, ¿ªÅ¬¸¯
  • reciprocal conduction
    »ó¹ÝÀüµµ
  • reciprocal crossing
    ¿ª±³¹è
  • reciprocal difference
    ¿ªÂ÷ºÐ
  • reciprocal hybrid
    »ó¹ÝÀâÁ¾
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • recessive heredity
    ¿­¼ºÀ¯Àü(¡­ë¶îî).
  • recessive homozygote
    ¿­¼ºÈ£¸ðÁ¢ÇÕü(¡­ïÈùêô÷).
  • recessive inheritance
    ¿­¼ºÀ¯Àü(¡­ë¶îî).
  • recessive lethals
    ¿­¼ºÄ¡»çÀÎ(¡­öÈÞÝì×).
  • recessive mutation
    ¿­¼ºµ¹¿¬º¯ÀÌ(æëàõÔÍæÔܨì¶).
  • recessive mutation
    ¿­¼ºµ¹¿¬º¯ÀÌ
  • recessive trait
    ¿­¼ºÇüÁú(¡­û¡òõ).
  • recessiveness
    ¿­¼º(æëàõ).
  • recessus alveolaris ³ª
    ÀÌÆ²<Ä¡Á¶>¿À¸ñ, Ä¡Á¶µ¹±â¿Í(öÍðËÔÍÑÃèÀ).
  • recessus anterior ³ª
    ¾Õ¿À¸ñ, ÀüÇÔ¿ä (îñùèèê).
  • recessus apicis
    ¹´
  • recessus bullaris
    »ç°ñÇÔ¿ä(ÞèÍéùèèê), »ç°ñ¿Í(ÞèÍéèÀ).
  • recessus bullaris ethmoidalis ³ª
    »ç°ñ¹úÁý ¿À¸ñ, »ç°ñÆ÷ÇÔ¿ä(ÞèÍéøàùèèê).
  • recessus canmerae posterioris ³ª
    µÚ¾È¹æÇÔ¿ä, ÈľȹæÇÔ¿ä(ý­äÑÛ®ùèèê).
  • recessus ileocecalis superior ³ª
    À§È¸Àå¸ÍÀå¿À¸ñ, »óȸ¸ÍÇÔ¿ä(ß¾üÞØîùèèê).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • receptor site
    ¼ö¿ëüºÎÀ§.
  • receptor stimulants
    ¼ö¿ëüÀÚ±ØÁ¦.
  • receptor supersensitivity
    ¼ö¿ëü Ãʰ¨¼ö¼º(áôéÄô÷ õ±Êïáôàõ)
  • receptor, T cell
    T¼¼Æ÷(Ç׿ø)¼ö¿ëü
  • receptor-ligand interaction
    ¼ö¿ëü-¹èÀ§ÀÚ »óÈ£ÀÛ¿ë
  • receptors
  • recess of infundibulum ³ª recessus infundibuli
    ±ò´ë±â¿À¸ñ, ´©µÎÇÔ¿ä( שÔà ùèèê).
  • recess of tympanic cavity
    °í½ÇÇÔ¿ä
  • recess of tympanic cavity
    °í½ÇÇÔ¿ä(ÍÕãøùèèê)
  • recess ³ª recessus
    ÇÔ¿ä(ùèèê), µ¿.
  • recess-resect
    ÈÄÀü-ÀýÁ¦¼ú
  • recesses of tympanic membrane
    °í¸·¿À¸ñ
  • recession
    ÅðÃà(÷Üõê).
  • recession
    ÈÄÀü, ÈÄÅð
  • recession of gum
    Ä¡ÀºÅðÃà(öÍó»÷Üõê).
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 9 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • rectus femoris muscle
    ´ëÅðÁ÷±Ù
  • rectus muscle
    Á÷±Ù
  • recumbency
    Ⱦ¿Í(À§)
  • recumbent position
    Ⱦ¿ÍÀ§
  • recurrence
    Àç¹ß, ¹Ýº¹, ȸ±Í(¼º)
  • recurrent
    Àç¹ßÀÇ, ¹Ýº¹ÀÇ, ȸ±â¼ºÀÇ
  • recurrent nerve
    µÇµ¹À̽Űæ, ¹Ýȸ½Å°æ
  • recurrent pyogenic cholangitis
    Àç¹ßÈ­³ó¼º´ã°ü¿°
  • recycle
    Àç¼øÈ¯
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • reciprocal disc
    ¿Õº¹¼º °üÀý ¿øÆÇ
  • reciprocal innervation
    »óÈ£ ½Å°æ Áö¹è, »óÈ£ ½Å°æ ºÐÆ÷
    °üÀýÀ» ½Î°í ÀÖ´Â ±ÙÀ°ÀÇ ½Å°æ Áö¹è. ¿©±â¿¡¼­´Â ¿îµ¿ ÁßÃß°¡ ½ÖÀ¸·Î °áÇÕÇÏ¿©, ÇÑÂÊÀÇ ÁßÃß°¡ ÀÚ±ØÀ» ÁÖ¾úÀ» ¶§ ´ëÀÀÇÏ´Â ÂÊ¿¡¼­´Â ¾ïÁ¦ÇÑ´Ù.
  • reciprocal retention
    »ó¹Ý Á¤Ã¼
  • reciprocating incline contact
    ´ëÇâ ±³µÎ »ç¸é Á¢ÃË
  • reciprocity
    »óÈ£¼º, »ó¹Ý¼º
  • Recklinghausen's disease
    Recklinghausen º´
    ´Ù¹ß, ´ÙÇü¼º ½Å°æ ¼¶À¯Á¾À̸ç, ±× ¹Û¿¡µµ »À, ÁßÃß ½Å°æ, ÀÚÀ² ½Å°æ µî¿¡µµ Á¾·ù¸¦ Çü¼ºÇÏ´Â ÇϳªÀÇ µ¶¸³ ÁúȯÀÌ´Ù. º´¸íÀº µ¶ÀÏÀÇ º´¸®ÇÐÀÚ F.D.von ·¹Å¬¸µÇÏ¿ìÁ¨
  • Recklinghausen's neurofibromatosis
    Recklinghausen ½Å°æ ¼¶À¯Á¾
    ½Å°æ°è, ±ÙÀ°, »À ¹× ÇǺÎÀÇ ¹ßÀ° º¯È­¸¦ Ư¡À¸·Î ÇÏ´Â °¡Á·¼º ÁúȯÀ¸·Î¼­, »ö¼Ò Ä§Âø ºÎÀ§¸¦ µ¿¹ÝÇÑ Àü½Å¿¡ ºÐÆ÷µÈ ´Ù¹ß¼º À¯°æ¼º ¿¬Á¾¾ç
  • reckoning test
    °¡»ê ½ÃÇè
  • recognition site
    ÀÎ½Ä ºÎÀ§
  • recoil
    ¹Ýµµ, µÇ²¿ÀÓ
  • recoil electron
    ¹Ýµµ ÀüÀÚ
  • recoil wave
    ºÒ±ÔÄ¢ ÆÄ
    ´ëµ¿¸ÆÆÇ Æó¼âÀÇ Ãæµ¿ÀÌ ¹Ý¿µµÇ¾î ÀϾ´Â ÆÄÀå.
  • recombinant plasminogen activator
    ÀçÁ¶ÇÕ Çö󽺹̳ë°Õ Ȱ¼ºÁ¦
  • recommended allowance
    Çã¿ë·®, ±ÇÀå·®
  • reconstitution
    À籸¼º
    1. »óó ÀÔÀº Ç¥¸é¿¡¼­ Á¶Á÷ÀÇ ½Å»ýº¸´Ù´Â Àç¹è¿­¿¡ ÀÇÇÑ »õ·Î¿î ±â°üÀÇ Àç»ý. 2. º¸ÀüÀ̳ª º¸°üÀ» À§ÇØ º¯Çü½ÃŲ ¹°ÁúÀ» ¿ø·¡ ÇüÅ·Πȸº¹ÇÏ´Â °Í. °ÇÁ¶ÇÑ »óÅ·Πº¸°üµÈ Ç÷û, Ç÷ÀåÀ» ¾×»óÀ¸·Î µÇµ¹¸®´Â °Í.
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
Receptors for activated C Kinase Synonym for endosome.
(18 Nov 1997)
receptors, adrenergic Cell-surface proteins that bind epinephrine and/or norepinephrine with high affinity and trigger intracellular changes. The two major classes of adrenergic receptors, alpha and beta, were originally discriminated based on their cellular actions but now are distinguished by their relative affinity for characteristic synthetic ligands. Adrenergic receptors may also be classified according to the subtypes of g-proteins with which they bind; this scheme does not respect the alpha-beta distinction.
(12 Dec 1998)
receptors, adrenergic, alpha One of the two major pharmacological subdivisions of adrenergic receptors. The alpha-beta distinction was originally based on cellular effects of receptor activation but now relies on the relative affinities for certain synthetic ligands. Alpha-adrenergic receptors are further subdivided into several subclasses based on studies of endogenous and cloned receptors.
(12 Dec 1998)
receptors, adrenergic, alpha-1 A subclass of alpha-adrenergic receptors (receptors, adrenergic, alpha). Alpha-1 adrenergic receptors can be pharmacologically discriminated, e.g., by their high affinity for the agonist phenylephrine and the antagonist prazosin. They are widespread, with clinically important concentrations in the liver, the heart, vascular, intestinal, and genitourinary smooth muscle, and the central and peripheral nervous systems.
(12 Dec 1998)
receptors, adrenergic, alpha-2 A subclass of alpha-adrenergic receptors (receptors, adrenergic, alpha). Alpha-2 adrenergic receptors can be pharmacologically discriminated, e.g., by their high affinity for the agonist clonidine and the antagonist yohimbine. They are found on pancreatic beta cells, platelets, and vascular smooth muscle, as well as both pre- and postsynaptically in the central and peripheral nervous systems.
(12 Dec 1998)
receptors, adrenergic, beta One of the two major pharmacologically defined classes of adrenergic receptors. The alpha-beta distinction was originally based on the cellular effects of receptor activation but now relies on the relative affinities for characteristic synthetic ligands. Beta adrenergic receptors are further subdivided based on information from endogenous and cloned receptors.
(12 Dec 1998)
receptors, adrenergic, beta-1 A subclass of beta-adrenergic receptors (receptors, adrenergic, beta). Beta-1 adrenergic receptors are equally sensitive to epinephrine and norepinephrine and bind the agonist dobutamine and the antagonist metoprolol with high affinity. They are found in the heart, juxtaglomerular cells, and in the central and peripheral nervous systems.
(12 Dec 1998)
receptors, adrenergic, beta-2 A subclass of beta-adrenergic receptors (receptors, adrenergic, beta). Beta-2 adrenergic receptors are more sensitive to epinephrine than to norepinephrine and have a high affinity for the agonist terbutaline. They are widespread, with clinically important roles in skeletal muscle, liver, and vascular, bronchial, gastrointestinal, and genitourinary smooth muscle.
(12 Dec 1998)
receptors, albumin Cell surface proteins that bind albumin with high affinity and trigger intracellular changes influencing the behaviour of cells.
(12 Dec 1998)
receptors, aldosterone Cytoplasmic proteins that specifically bind aldosterone and mediate its cellular effects. The aldosterone-bound receptor acts in the nucleus to regulate the transcription of specific segments of DNA.
(12 Dec 1998)
receptors, amino acid Cell surface proteins that bind amino acids and trigger changes which influence the behaviour of cells. Glutamate receptors are the most common receptors for fast excitatory synaptic transmission in the vertebrate central nervous system, and gaba and glycine receptors are the most common receptors for fast inhibition.
(12 Dec 1998)
receptors, ampa Cell surface proteins that bind glutamate and directly gate ion channels in cell membranes. Ampa receptors were originally discriminated from other glutamate receptors by their affinity for the agonist ampa (alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid). They are probably the most common mediators of fast excitatory synaptic transmission in the central nervous system. Several subtypes have been cloned, and for some types the traditional distinction from kainate receptors may not apply.
(12 Dec 1998)
receptors, androgen Proteins, generally found in the cytoplasm, that specifically bind androgens and mediate their cellular actions. The complex of the androgen and receptor migrates to the nucleus where it induces transcription of specific segments of DNA.
(12 Dec 1998)
receptors, angiotensin Cell surface proteins that bind angiotensins and trigger intracellular changes influencing the behaviour of cells.
(12 Dec 1998)
receptors, antigen Molecules on the surface of b- and T-lymphocytes that recognise and combine with specific antigens.
(12 Dec 1998)
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 5 ÆäÀÌÁö: 4
  • Receptor, Cannabinoid, CB2 - »õâ A subclass of cannabinoid receptor found primarily on immune cells where it may play a role modulating release of CYTOKINES.
    Synonyms : CB2 Receptor, CB2, Cannabinoid Receptor, Receptor CB2, Cannabinoid, Receptor, CB2
  • Receptor, Cholecystokinin A - »õâ A subtype of cholecystokinin receptor found primarily in the PANCREAS; STOMACH; INTESTINE; and GALLBLADDER. It plays a role in regulating digestive functions such as gallbladder contraction, pancreatic enzyme secretion and absorption in the GASTROINTESTINAL TRACT.
    Synonyms : CCK(1) Receptor, A Receptor, Cholecystokinin, CCK A Receptor, Receptor, CCK-A
  • Receptor, Cholecystokinin B - »õâ A subtype of cholecystokinin receptor found primarily in the CENTRAL NERVOUS SYSTEM and the GASTRIC MUCOSA. It may play a role as a neuromodulator of dopaminergic neurotransmission the regulation of GASTRIC ACID secretion from GASTRIC PARIETAL CELLS.
    Synonyms : CCK-B Receptors, CCK2 Receptor, CKK-2 Receptor, Cholecystokinin B Receptor, Cholecystokinin-2 Receptor, Gastrin Receptor, Receptor, CCK-B, B Receptor, Cholecystokinin, CCK B Receptor, CCK B Receptors, CKK 2 Receptor, Cholecystokinin 2 Receptor, Gastrin Receptors
  • Receptor, Ciliary Neurotrophic Factor - »õâ Cell surface receptors for CILIARY NEUROTROPHIC FACTOR. They are heterotrimeric proteins formed by the association of the CILIARY NEUROTROPHIC FACTOR RECEPTOR ALPHA SUBUNIT with the LEUKEMIA INHIBITOR FACTOR RECEPTOR ALPHA SUBUNIT and the CYTOKINE RECEPTOR GP130. Although the receptor regulates neuronal development, it is structurally similar to the cytokine receptor for INTERLEUKIN-6; (RECEPTORS, INTERLEUKIN-6).
    Synonyms : Receptor, CNTF
  • Receptor, Endothelin A - »õâ A subtype of endothelin receptor found predominantly in the VASCULAR SMOOTH MUSCLE. It has a high affinity for ENDOTHELIN-1 and ENDOTHELIN-2.
    Synonyms : Receptor, Endothelin-1, Endothelin A Receptor, Endothelin-1 Receptor, Receptor, Endothelin 1, Receptors, Endothelin A
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 5 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 10 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
º£³×ÇȽºÁÖ - »õâ
Çѱ¹¿ÍÀ̾
E30540401 Recombinant blood coagulation factor IX
Àü¹®ÀǾàǰ | »èÁ¦
¸®ÄÞºñ³×ÀÌÆ® - »õâ
¹Ú½ºÅÍ
E04270381 Recombinant blood coagulation factor VIII
Àü¹®ÀǾàǰ | ±Þ¿©
·¹ÄÚ½ºÅ¸Á¤ - »õâ
¸í¹®Á¦¾à
A31804201 Rebamipide
Àü¹®ÀǾàǰ | ±Þ¿©
·¹ÄÚºñÁ¤ - »õâ
Çѱ¹ÇÁ¶óÀÓÁ¦¾à
A62700551 Biphenyl Dimethyl Dicarboxylate
Àü¹®ÀǾàǰ | ±Þ¿©
ÈÒ³ªÀÎÁÖ250IU - »õâ
³ì½ÊÀÚ
A35504461 Recombinant blood coagulation factor IX
Àü¹®ÀǾàǰ | ±Þ¿©
¸®ÄÚ¸óÇÁ¸®ÇʵåÁÖ6000IU - »õâ
Áß¿Ü
E02690551 Recombinant erythropoietin beta
Àü¹®ÀǾàǰ | ±Þ¿©
·¹°í±¸¹ÎÁÖ250mg - »õâ
Çѱ¹½´³ÚÁ¦¾à
A07152741 Citicoline
Àü¹®ÀǾàǰ | ±Þ¿©
¸®ÄÚ¸óÁÖ»ç¾×ÇÁ¸®Çʵå½Ã¸°Áö10000¾ÆÀÌÀ¯ - »õâ
Áß¿Ü
E02690561 Recombinant erythropoietin beta
Àü¹®ÀǾàǰ | ±Þ¿©
·¹Ä«µöÁ¤ - »õâ
µå¸²ÆÄ¸¶
A35104531 Lercanidipine HCl
Àü¹®ÀǾàǰ | ±Þ¿©
º£³×ÇȽºÁÖ - »õâ
Çѱ¹¿ÍÀ̾
E30540581 Recombinant blood coagulation factor IX
Àü¹®ÀǾàǰ | ±Þ¿©
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
rectified having been put right
Ãâó: wordnet.princeton.edu/perl/webwn
recapitulation palingenesis: emergence during embryonic development of various characters or structures that appeared during the evolutionary history of the strain or species (music) the section of a composition or movement (especially in sonata form) in which musical themes that were introduced earlier are repeated a summary at the end that repeats the substance of a longer discussion
Ãâó: wordnet.princeton.edu/perl/webwn
rectosigmoid of or related to or near the sigmoid colon and the upper part of the rectum
Ãâó: wordnet.princeton.edu/perl/webwn
recirculation circulation again
Ãâó: wordnet.princeton.edu/perl/webwn
recoil flinch: draw back, as with fear or pain; "she flinched when they showed the slaughtering of the calf" backfire: come back to the originator of an action with an undesired effect; "Your comments may backfire and cause you a lot of trouble" the backward jerk of a gun when it is fired bounce: spring back; spring away from an impact; "The rubber ball bounced"; "These particles do not resile but they unite after they collide" a movement back from an impact kick back: spring back, as from a forceful thrust; "The gun kicked back into my shoulder"
Ãâó: wordnet.princeton.edu/perl/webwn
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • recede
    ¹°·¯°¡´Ù;¾¦ µé¾î°¡´Ù;¿òÇ«µé¾î°¡´Ù;µÚÆíÀ¸·Î ±â¿ï´Ù;(°è¾à µî¿¡¼­)¼ÕÀ» ¶¼´Ù;(ÁÖÀå µîÀ»)°ÅµÎ´Ù;¿òÃ÷·¯Áö´Ù;°¨Åð(°¨¼Ò)ÇÏ´Ù;(°¡Ä¡.ǰÁúµîÀÌ)¶³¾îÁö´Ù;³ªºüÁö´Ù;(ÀλóÀÌ)Èñ¹ÌÇØÁö´Ù
  • recede
    (º»·¡ÀÇ ¼ÒÀ¯ÀÚ¿¡°Ô)¹ÝȯÇÏ´Ù
  • receding color
    ÈÄÅð»ö(ÆÄ¶û.ÃÊ·Ï.ÀÚÁÖ µî)
  • receipt
    ¿µ¼öÁõ
  • receipt
    ¹ÞÀ½;¿µ¼ö;¼öÃë;¹ÞÀº ¹°°Ç;¼ö·É¾×;¿µ¼öÁõ;=RECIPE;(°è»ê¼­¿¡)¿µ¼öÇÊ(Received)À̶ó°í ¾²´Ù;¿µ¼öÁõÀ» ¹ßÇàÇÏ´Ù
  • receipt book
    ¼ö·É´ëÀå;¿µ¼öÁõö
  • receipt stamp
    ¼öÀÔ ÀÎÁö
  • receiptor
    ¼ö·ÉÀÚ;¾Ð·ù¹° º¸°üÀÚ
  • receipts
    Àμö
  • receivable
    ¹ÞÀ»¼ö ÀÖ´Â
  • receivable
    ¹ÞÀ» ¼ö ÀÖ´Â;¹ÞÀ» ¸¸ÇÑ;¹ÏÀ» ¸¸ÇÑ;¼öÃë°èÁ¤(¾îÀ½)
  • receive
    ¹Þ´Ù,°æÇèÇÏ´Ù,´çÇÏ´Ù,¸·¾Æ³»´Ù,¼ö½ÅÇÏ´Ù
  • receive
    ¹Þ´Ù;¼öÃëÇÏ´Ù;¾ò´Ù;(½Åû µîÀ»)Á¢¼öÇÏ´Ù;¼ö¸®ÇÏ´Ù;(Èû.¹«°Ô.ÀûµîÀ»)¹Þ¾Æ³»´Ù;¹öƼ´Ù;¿ä°ÝÇÏ´Ù;¹Þ¾Æ ³Ö´Ù;¼ö¿ëÇÏ´Ù;¸Â¾ÆµéÀÌ´Ù;ȯ¿µÇÏ´Ù;Á¢°ßÇÏ´Ù;(±³À°.ÈÆ·ÃÀ»)¹Þ´Ù;°æÇèÇÏ´Ù;(µ¿Á¤.¸ð¿å.Ÿ°Ý µîÀ»)¹Þ´Ù;ÀÔ´Ù;ÀÌÇØÇÏ´Ù;¹Ï´Ù;¿ëÀÎÇÏ´Ù;¹Þ¾ÆµéÀÌ´Ù;(ÈÉÄ£ ¹°°ÇÀ»)»çµéÀÌ´Ù;°í¸Å
  • received
    ÀÎÁ¤¹Þ°í ÀÖ´Â
  • received
    ¹Þ¾Æµé¿©Áø;¹Ï¾îÁö°í ÀÖ´Â;¿ëÀεÈ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 12 ÆäÀÌÁö: 4
REC take back by force, as after a battle
REC cast or model anew
REC cast again
REC cast again, in a different role
REC changing a particular word or phrase
REC reconnaissance (by shortening)
REC reconnaissance (by shortening)
REC reconnaissance (by shortening)
REC become faint or more distant
REC retreat
REC move back and away from
REC pull back or move away or backward
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 5 ÆäÀÌÁö: 4
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
ÅëÇÕ°Ë»ö ¿Ï·á